Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED | 1 | ₹1.2 Cr |
| 2 | Schedule 2 | MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED | 1 | ₹23.4 L |
| 3 | Schedule 3 | MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED | 1 | ₹23.4 L |
| 4 | Schedule 4 | MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED | 1 | ₹23.4 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
24 May 2024, 5:00 pmClosed
(Excise Duty
Insurance
Transportation and Incidental charges extra) 743d563fdddc8bbdf74c5dc82f 24c2be.pdf
(Excise Duty
Insurance
Transportation and Incidental charges extra) 7fe8fe2c26171fb6d22b173100 1a59c8.pdf
600c6dc.pdf
6301621
GEM/2024/B/4851687
Two Packet Bid
Automated system for molecular detection of MTB and resistance to Rifampicin for Bhutan,Automated s
GeM Contract
42 days
Delhi; South Delhi
Item wise evaluation
PRODUCT_CUSTOM
Awarded to MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED
₹85 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Automated system for molecular detection of MTB and resistance to Rifampicin | Mylab Discovery Solutions Pvt Ltd / Compact XL and Compact Q | HSN not specified by seller | 5 set | 1,700,000 | 8,500,000 |
Awarded to MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED
₹17 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Automated system for molecular detection of MTB and resistance to Rifampicin | Mylab Discovery Solutions Pvt Ltd / Compact XL and Compact Q | HSN not specified by seller | 1 set | 1,700,000 | 1,700,000 |
Awarded to MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED
₹17 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Automated system for molecular detection of MTB and resistance to Rifampicin | Mylab Discovery Solutions Pvt Ltd / Compact XL and Compact Q | HSN not specified by seller | 1 set | 1,700,000 | 1,700,000 |
Awarded to MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED
₹17 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Automated system for molecular detection of MTB and resistance to Rifampicin | Mylab Discovery Solutions Pvt Ltd / Compact XL and Compact Q | HSN not specified by seller | 1 set | 1,700,000 | 1,700,000 |
9 documents required · 9 mandatory
3 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| (Excise Duty, Insurance, Transportation and Incidental charges extra) 743d563fdddc8bbdf74c5dc82f 24c2be.pdf | - | - | - |
| (Excise Duty, Insurance, Transportation and Incidental charges extra) 7fe8fe2c26171fb6d22b173100 1a59c8.pdf | - | - | - |
| 600c6dc.pdf | - | - | - |
Exempted
19 Nov 2024
3 May 2024
24 May 2024
contract_GEMC-511687737415706.pdf
GEM_CONTRACT • 0.11 MB
contract_GEMC-511687758003334.pdf
GEM_CONTRACT
contract_GEMC-511687759301997.pdf
GEM_CONTRACT
contract_GEMC-511687778822567.pdf
GEM_CONTRACT
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6301621.pdf
GEM_BID
final_technical_sepcifications_bhutan_2024-04-09-21-49-26_7a1fe95bd8997bbad671de25964b8225.pdf
SPECIFICATION
final_technical_sepcifications_srilanka_2024-04-09-21-53-04_04af9b7c45679378f0b518a4eb6954a9.pdf
SPECIFICATION
final_technical_sepcifications_nepal_2024-04-09-21-55-18_b4d6f5c7ddb2964ca03d7a6a4b480073.pdf
SPECIFICATION
final_technical_sepcifications_indonesia_2024-04-09-21-43-23_db6833eb0ad336da98c39ccf7afe81f3.pdf
SPECIFICATION
1712681426.xlsx
OTHER
743d563fdddc8bbdf74c5dc82f24c2be.pdf
OTHER
7fe8fe2c26171fb6d22b1731001a59c8.pdf
OTHER
00a35207f0835dfd461268a38a299af9.pdf
OTHER
7607128b0ece3f808a84ddd39600c6dc.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .